跳至主要内容
临床试验/CTRI/2025/05/086156
CTRI/2025/05/086156尚未招募2/3 期

A Randomised controlled clinical study of Kallurvanjyadi Kashaya in the management of Pittaja Mutrakrichra.

Dr.Akash R Terdal1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2025年5月15日最近更新:

试验速览

阶段
2/3 期
状态
尚未招募
发起方
入组人数
40
试验地点
1
主要终点
To evaluate the efficacy of Kallurvanjyadi Kashaya in the management of Pittaja Mutrakrichra.

研究概览

简要总结

This research protocol aims to compare the therapeutic effectiveness of Kallurvanjyadi Kashaya and Haritakyadi Kwatha in managing Pittaja Mutrakrichra an Ayurvedic condition characterized by difficult micturition and symptoms resembling Lower Urinary Tract Infection (UTI). The study will be a randomized controlled clinical trial involving 40 patients divided into two groups each receiving one of the two Kashayas for seven days. Subjective parameters like burning micturition, painful micturition, and frequency along with objective urine analysis parameters (pus cells, epithelial cells, RBCs) will be assessed at baseline, day 8 and day 14. The study seeks to evaluate if Kallurvanjyadi Kashaya is more effective than the standard Haritakyadi Kwatha in alleviating the symptoms of Pittaja Mutrakrichra.

研究设计

研究类型
Interventional
分配方式
Computer generated randomization
盲法
Participant Blinded

入排标准

年龄范围
18.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • Patients who will fulfill the diagnostic criteria.
  • Patients with age group between 18 to 60 years (Both age inclusive).
  • Patients who are willing to enroll in the research and sign the consent form.

排除标准

  • •Pittaja mutrakrichra due to bastimarmabhighata.
  • •Patients having STD •Patient with Congenital Deformity •Secondary to a disorder like Renal Calculi, BPH, Acute Renal Failure, Diabetes mellitus, vesico-ureteric reflux, malignancy related to genitourinary tract, Renal Tuberculosis.
  • •Pregnant and Lactating women will be excluded.

结局指标

主要结局

To evaluate the efficacy of Kallurvanjyadi Kashaya in the management of Pittaja Mutrakrichra.

时间窗: 15 days

次要结局

  • objective parameter assessed(Pus Cells / hpf)

研究者

发起方
Dr.Akash R Terdal
申办方类型
Other [self]

研究点 (1)

Loading locations...

相似试验